REPYY vs. ELVN
REPYY (Repsol SA) and ELVN (Enliven Therapeutics Inc.) are both stocks. REPYY operates in Oil & Gas Integrated (Energy), while ELVN operates in Biotechnology (Healthcare). Over the past 5 years, REPYY returned 20.20%/yr vs 9.13%/yr for ELVN. At a 0.09 correlation, their price movements are largely independent.
Performance
REPYY vs. ELVN - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, REPYY achieves a 37.45% return, which is significantly lower than ELVN's 215.58% return.
REPYY
- 1D
- 0.08%
- 1M
- -3.94%
- YTD
- 37.45%
- 6M
- 37.37%
- 1Y
- 84.58%
- 3Y*
- 29.28%
- 5Y*
- 20.20%
- 10Y*
- 14.23%
ELVN
- 1D
- 5.74%
- 1M
- 17.00%
- YTD
- 215.58%
- 6M
- 194.01%
- 1Y
- 139.53%
- 3Y*
- 32.11%
- 5Y*
- 9.13%
- 10Y*
- —
REPYY vs. ELVN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
REPYY Repsol SA | 37.45% | 66.69% | -13.03% | -2.01% | 41.58% | 20.97% | 17.91% |
ELVN Enliven Therapeutics Inc. | 215.58% | -31.56% | 62.57% | -15.40% | 81.78% | -89.80% | 57.50% |
Correlation
The correlation between REPYY and ELVN is -0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.04 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.07 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.09 |
Correlation (All Time) Calculated using the full available price history since Mar 12, 2020 | 0.09 |
The correlation between REPYY and ELVN shifts across timeframes, from -0.04 (1 year) to 0.09 (all time), reflecting how their relationship changes across market environments.
Fundamentals
REPYY:
$28.21B
ELVN:
$3.05B
REPYY:
€2.16
ELVN:
-$1.69
REPYY:
0.95
ELVN:
6.73
REPYY:
€55.91B
ELVN:
$0.00
REPYY:
€10.82B
ELVN:
-$46.00K
REPYY:
€6.32B
ELVN:
-$110.65M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
REPYY vs. ELVN — Risk / Return Rank
REPYY
ELVN
REPYY vs. ELVN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Repsol SA (REPYY) and Enliven Therapeutics Inc. (ELVN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| REPYY | ELVN | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.14 | ||
| Sortino ratioReturn per unit of downside risk | +0.29 | ||
| Omega ratioGain probability vs. loss probability | 1.45 | 1.33 | +0.12 |
| Calmar ratioReturn relative to maximum drawdown | 4.91 | 3.81 | +1.10 |
| Martin ratioReturn relative to average drawdown | 15.02 | 9.71 | +5.30 |
Loading charts...
Drawdowns
REPYY vs. ELVN - Drawdown Comparison
The maximum REPYY drawdown since its inception was -65.56%, smaller than the maximum ELVN drawdown of -98.20%. Use the drawdown chart below to compare losses from any high point for REPYY and ELVN.
Loading charts...
Drawdown Indicators
| REPYY | ELVN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -65.56% | -98.20% | +32.64% |
Max Drawdown (1Y)Largest decline over 1 year | -17.30% | -36.84% | +19.54% |
Max Drawdown (3Y)Largest decline over 3 years | -34.63% | -51.94% | +17.31% |
Max Drawdown (5Y)Largest decline over 5 years | -35.71% | -87.90% | +52.19% |
Max Drawdown (10Y)Largest decline over 10 years | -65.56% | — | — |
Current DrawdownCurrent decline from peak | -12.78% | -77.86% | +65.08% |
Average DrawdownAverage peak-to-trough decline | -15.95% | -84.14% | +68.19% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.65% | 14.43% | -8.78% |
Volatility
REPYY vs. ELVN - Volatility Comparison
The current volatility for Repsol SA (REPYY) is 8.77%, while Enliven Therapeutics Inc. (ELVN) has a volatility of 23.83%. This indicates that REPYY experiences smaller price fluctuations and is considered to be less risky than ELVN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| REPYY | ELVN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.77% | 23.83% | -15.06% |
Volatility (6M)Calculated over the trailing 6-month period | 25.63% | 61.30% | -35.67% |
Volatility (1Y)Calculated over the trailing 1-year period | 29.89% | 81.98% | -52.09% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 28.50% | 86.22% | -57.72% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 31.98% | 88.05% | -56.07% |
Dividends
REPYY vs. ELVN - Dividend Comparison
REPYY's dividend yield for the trailing twelve months is around 4.67%, while ELVN has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
ELVN Enliven Therapeutics Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
REPYY Repsol SA | 4.67% | 5.69% | 8.07% | 5.03% | 4.22% | 2.41% | 8.21% | 8.35% | 2.97% | 4.31% | 3.89% |
Financials
REPYY vs. ELVN - Financials Comparison
This section allows you to compare key financial metrics between Repsol SA and Enliven Therapeutics Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
REPYY and ELVN have a correlation of -0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ELVN has higher volatility (23.83%) compared to REPYY (8.77%). In terms of maximum drawdown, REPYY dropped -65.56% vs ELVN's -98.20%.
REPYY currently has the higher Sharpe Ratio (2.85 vs 1.72), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for REPYY and ELVN
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer